Blog

Ketamine-assisted psychotherapy is a relatively new treatment that is gaining in popularity. This type of therapy involves ketamine, a drug that has been used for decades but only recently have we started to unlock its secrets to treat depression and other mental health conditions.   Today, we will look at what ketamine-assisted psychotherapy is and how it can be a benefit to the patient....

Mental health is a huge issue in the United States, and more and more people are struggling with mental health conditions. The COVID-19 pandemic hasn’t done anything to improve the situation either: With the extra stress, uncertainty, and instability millions of people are facing due to the pandemic, mental health issues are at an all-time high.    According to the National Institute of...

Results Distinguish Deep TMS as More Effective in Subjects with Higher Anxiety Symptoms, Long Considered Less Responsive to Alternative Treatments BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today...

Sandhya Prashad, MD is the medical director at Houston Ketamine Therapeutics and Houston Deep Transcranial Magnetic Stimulation (TMS) Therapy. There is no question that the pandemic has shaped myriad aspects of life as we know it, including significantly impacting the mental health care industry. While the unprecedented events have resulted in mental health challenges, it has also delivered...

BELLAIRE, Texas, Aug. 11, 2020 /PRNewswire/ — Ketamine, which was originally developed as an anesthetic, has emerged over the last two decades as the biggest breakthrough in 50 years for treatment-resistant depression and suicidality. Despite a growing body of research surrounding its use, guidelines establishing recommendations for best practices have been limited. The American Society...

This past week the American Journal of Psychiatry published an exciting new study “Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT),” which is highlighted in this recent piece in Inverse. We interviewed our Chief Services Officer and co-founder Owen Muir, MD, who was excited to explain how this treatment works, why it’s so important, and how...

An accelerated, high-dose transcranial magnetic stimulation (TMS) therapy significantly improved depression symptoms in a small, open-label study. (more…)

The Food and Drug Administration has approved a variant of the anesthetic and party drug ketamine for suicidal patients with major depression. (more…)

A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms in those with major depressive disorder who have imminent risk of suicidal ideation, according to Houston-based psychiatrist Sandhya Prashad. “The original indication for treatment-resistant depression meant that patients had failed treatments...

An option for people who don’t see successful results from standard depression treatments like talk therapy or antidepressants is transcranial magnetic stimulation (TMS). Research shows that this non-invasive technique, which uses electromagnetic fields to stimulate nerve cells in the brain, can fill the therapeutic void left when other treatments fail. (more…)